Kenya

Kenya aligned its position with the African regional statement presented by Zimbabwe on behalf of the WHO African Region, reinforcing a continent-wide call for equity at the heart of global health governance and emergency response.

WHO validated the elimination in June 2025, and Kenya made a national announcement in August 2025 before formally receiving the certification in Geneva.

Under the partnership, IVI will collaborate closely with institutions such as the Kenya Medical Research Institute, the Kenya BioVax Institute, and the Pharmacy and Poisons Board to support vaccine development, manufacturing, and regulatory strengthening.

The next phase will focus on installing and validating fill-and-finish equipment, strengthening quality control systems, building specialized workforce capacity, and preparing for compliant vaccine manufacturing.

Through the proposed partnership, Africa CDC and Aspen plan to establish a multi-year collaboration to boost local manufacturing capacity, improve supply security, and create sustainable markets for African-made vaccines.

The financing consortium includes Proparco, the European Investment Bank through the Human Development Accelerator initiative, and the International Finance Corporation.

The procedure, known as intraoperative pathological assessment using imprint cytology, enables pathologists to identify cancer cells within minutes.

The newly installed LINAC machine is projected to double the hospital’s radiotherapy treatment capacity from 70 to 140 patients daily.

Dr. Melly currently serves as Kenya’s cancer country counterpart lead for the International Atomic Energy Agency and is affiliated with several global oncology bodies, including the Union for International Cancer Control and the Association of American Cancer Institutes.

Using the new setup, clinicians can treat multiple oral conditions during one theatre session under general anaesthesia.